ProQR Therapeutics N.V.
PRQR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $107 | $120 | $143 | $149 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $3 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $5 | $3 | $4 |
| Total Curr. Assets | $111 | $124 | $149 | $154 |
| Property Plant & Equip (Net) | $13 | $13 | $15 | $14 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $13 | $13 | $15 | $14 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $124 | $138 | $164 | $168 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $0 | $0 |
| Short-Term Debt | $6 | $6 | $5 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $21 | $0 |
| Other Curr. Liab. | $26 | $25 | $10 | $33 |
| Total Curr. Liab. | $33 | $33 | $36 | $39 |
| LT Debt | $10 | $10 | $12 | $11 |
| Deferred Rev, NC | $0 | $0 | $31 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $24 | $27 | $0 | $29 |
| Total NC Liab. | $34 | $37 | $42 | $40 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $12 | $12 | $12 | $13 |
| Total Liabilities | $67 | $71 | $79 | $79 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $57 | $4 | $5 | $4 |
| Retained Earnings | $0 | -$448 | -$471 | -$427 |
| AOCI | $0 | $27 | $29 | $28 |
| Other Equity | $0 | $484 | $523 | $484 |
| Total Equity | $57 | $67 | $85 | $89 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $124 | $138 | $164 | $168 |
| Net Debt | -$90 | -$103 | -$127 | -$132 |